Abstract SummaryScreening and appropriate treatment for osteoporosis has been proven to be cost-effective in many populations; however, it is not clear in the Chinese population. Simulations using a validated health economics model suggest that screening for osteoporosis in Chinese women is cost-effective and may even be cost-saving in Chinese post-menopausal women. IntroductionThis study aimed at determining the cost-effectiveness of osteoporosis screening strategies in post-menopausal Chinese women. MethodsA validated state-transition microsimulation model with a lifetime horizon was used to evaluate the cost-effectiveness of different screening strategies with treatment of alendronate compared with current osteoporosis management in China. Osteoporosis screening strategies assessed were (1) universal screening with dual-energy X-ray absorptiometry (DXA) alone; (2) Osteoporosis Self-Assessment Tool for Asians (OSTA) + DXA; and (3) quantitative ultrasound (QUS) + DXA with rescreening at 2, 5 or 10-year intervals for patients screened negative by DXA. The study was performed from the Chinese healthcare payer’s perspective. All model inputs were retrieved from publically available literature. Uncertainties were addressed by one-way and probabilistic sensitivity analysis. ResultsScreening strategies all improved clinical outcomes at increased costs, and each were cost-effective compared with no screening in women aged 55 years given the Chinese willingness-to-pay threshold of USD 20,000 per quality-adjusted life year (QALY) gained. Pre-screening with QUS and subsequent DXA screening if the QUS T-score ≤ −0.5 with a 2-year rescreening interval was the most cost-effective strategy with the highest probability of being cost-effective across all non-dominated strategies. Screening strategies were cost-saving if screenings were initiated from age 65 years. One-way sensitivity analyses indicated that the results were robust. ConclusionsPre-screening with QUS with subsequent DXA screening if the QUS T-score ≤ −0.5 with a 2-year rescreening interval in the Chinese women starting at age 55 is the most cost-effective. In addition, screening and treatment strategies are cost-saving if the screening initiation age is greater than 65 years.
QUS                 0.9967858007055791^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Qus                   

DXA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

Chinese                       0.9923528132276488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

Osteoporosis                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Osteoporosis          

sensitivity analysis          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Sensitivity_analysis  

literature                    0.999997928061348^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Literature            

interval                      0.9999475018896268^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Level_of_measurement  

post-menopausal               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Menopause             

quality-adjusted life year    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Quality-adjusted_life_year

QUS                           0.9967858007055791^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Qus                   

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

healthcare                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Health_care           

Chinese                       0.9923528132276488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

DXA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

USD                           0.9999999972833393^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States_dollar  

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

health economics              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Health_economics      

probability                   0.9996353222122656^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Probability           

horizon                       0.9808509969835086^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Observable_universe   

Chinese                       0.9923528132276488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

sensitivity                   0.999999649843919^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Sensitivity_analysis  

osteoporosis                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Osteoporosis          

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

Chinese population            0.39635204755257913^^http://www.w3.org/2001/XMLSchema#double          http://dbpedia.org/resource/Chinese_American      

QALY                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Quality-adjusted_life_year

initiation                    0.9892381414840333^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Transcription_(genetics)

QUS                           0.9967858007055791^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Qus                   

DXA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

T-score                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bone_density          

osteoporosis                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Osteoporosis          

cost-effectiveness            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cost-effectiveness_analysis

post-menopausal               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Menopause             

osteoporosis                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Osteoporosis          

ultrasound                    0.9999863582930251^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ultrasound            

cost-effectiveness            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cost-effectiveness_analysis

Osteoporosis                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Osteoporosis          

quantitative                  0.9982830279253404^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Statistics            

universal screening           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Screening_(medicine)  

Chinese                       0.9923528132276488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

Chinese                       0.9923528132276488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

China                         0.9988301874971346^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

DXA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

T-score                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bone_density          

QUS                           0.9967858007055791^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Qus                   

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

DXA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

Chinese                       0.9923528132276488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/China                 

osteoporosis                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Osteoporosis          

Self-Assessment               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Self-assessment       

QUS                           0.9967858007055791^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Qus                   

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

dual-energy X-ray absorptiometry1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

willingness-to-pay            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Willingness_to_pay    

probabilistic                 0.9972875279950554^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Probability           

Tool                          0.9945789241914279^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tool                  

microsimulation               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Microsimulation       

interval                      0.9999475018896268^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Level_of_measurement  

DXA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dual-energy_X-ray_absorptiometry

intervals                     0.9992928033822897^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Time                  

screening                     0.9998541035687262^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Screening_(medicine)  

alendronate                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Alendronic_acid       

